Clinical Study
Gender-Specific Variation in the Prognosis of Papillary Thyroid Cancer TNM Stages II to IV
Table 2
Multiple regression analysis for factors associated with postoperative progression.
| |
SE | Standardized coefficient | value | value | 95% confidence interval | Lower | Upper |
| Intercept | 0.2438 | −0.677 | −2.724 | 0.007 | −1.167 | −0.186 | Age | 0.004 | 0.10 | 1.533 | 0.127 | −0.002 | 0.012 | Followup period | 0.005 | −0.049 | −0.711 | 0.478 | −0.014 | 0.006 | Postoperative one month 131I uptake | 0.004 | 0.119 | 1.772 | 0.078 | −0.001 | 0.014 | Gender: female/male | 0.068 | 0.251 | 3.672 | 0.000 | 0.115 | 0.383 | Postoperative one month Tg | 0.001 | 0.206 | 2.907 | 0.004 | 0.000 | 0.002 | TNM stage | 0.035 | 0.175 | 2.576 | 0.011 | 0.021 | 0.157 |
|
|
Dependent variable: postoperative progression (no/yes).
|